Cargando…

Management of Heparin-Induced Thrombocytopenia with Fondaparinux in a Patient with Left Ventricular Assist Device

Heparin-induced thrombocytopenia is an immune-mediated serious adverse effect of heparin therapy. It is a relatively frequent complication among patients with mechanical circulatory support. Herein, we present a patient with severe heart failure and sepsis who developed heparin-induced thrombocytope...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velagic, V., Samardzic, J., Baricevic, Z., Skoric, B., Cikes, M., Gasparovic, H., Biocina, B., Milicic, D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Avicenna Organ Transplantation Institute 2014
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089335/ https://www.ncbi.nlm.nih.gov/pubmed/25013684

Ejemplares similares

A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients
por: Benken, Scott T, et al.
Publicado: (2014)

The Fondaparinux Paradox: Fondaparinux-Related Heparin-induced Thrombocytopenia
por: Vadi, Sonali, et al.
Publicado: (2018)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Failure of Fondaparinux in Autoimmune Heparin-Induced Thrombocytopenia
por: Sartori, Michelangelo, et al.
Publicado: (2020)

Influence of atrial ultrastructural remodeling on its early mechanical transport following surgery for atrial fibrillation and mitral insufficiency
por: Kopjar, T, et al.
Publicado: (2013)

Pretransplant and perioperative predictors of early heart transplantation outcomes
por: Gašparović, Hrvoje, et al.
Publicado: (2014)

Fondaparinux: another potential treatment for heparin-induced thrombocytopenia type II?
por: Honore, Patrick M., et al.
Publicado: (2016)

Fondaparinux in heparin‐induced thrombocytopenia: A decade's worth of clinical experience
por: Schindewolf, Marc
Publicado: (2018)

The use of cangrelor with heparin for left ventricular assist device implantation in a patient with acute heparin-induced thrombocytopenia
por: Gernhofer, Yan K., et al.
Publicado: (2018)

Fondaparinux-associated Thrombocytopenia
por: Malik, Jahanzeb, et al.
Publicado: (2021)

Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia
por: Ciurzyński, Michał, et al.
Publicado: (2011)

Systematic review of fondaparinux for heparin‐induced thrombocytopenia: When there are no randomized controlled trials
por: Linkins, Lori‐Ann, et al.
Publicado: (2018)

Fondaparinux sodium/heparin: Type II heparin-induced thrombocytopenia and drug cross reactivity: case report
Publicado: (2022)

Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report
por: He, Yumiao, et al.
Publicado: (2018)

When Will Fondaparinux Induce Thrombocytopenia?
por: Chen, Li-Yu, et al.
Publicado: (2022)

How does age affect outcomes after left ventricular assist device implantation: results from the PCHF‐VAD registry
por: Radhoe, Sumant P., et al.
Publicado: (2022)

A case of probable bemiparin-induced heparin-induced thrombocytopenia type II managed with low-dose fondaparinux
por: Koul, AN
Publicado: (2015)

Preponderance of microbial isolates among heart transplantation recipients requiring renal replacement therapy: a propensity score-adjusted analysis
por: Gašparović, Hrvoje, et al.
Publicado: (2018)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
por: Christopher, Amy
Publicado: (2016)

Contemporary challenges in the management of advanced heart failure
por: Gašparović, Hrvoje, et al.
Publicado: (2014)

Sex‐related differences in left ventricular assist device utilization and outcomes: results from the PCHF‐VAD registry
por: Radhoe, Sumant P., et al.
Publicado: (2022)

Fondaparinux for intra and perioperative anticoagulation in patients with heparin-induced thrombocytopenia candidates for peripheral vascular surgery: Report of 4 cases
por: Illuminati, Giulio, et al.
Publicado: (2016)

Fondaparinux for systemic anticoagulation during continuous hemofiltration in a patient with heparin-induced thrombocytopenia and limb ischemia – a case report
por: Osawa, Eduardo Atsushi, et al.
Publicado: (2022)

Successful ventricular tachycardia ablation in a patient with a biventricular ventricular assist device and heparin-induced thrombocytopenia using bivalirudin
por: Ho, Gordon, et al.
Publicado: (2018)

Azd-1222/fondaparinux-sodium/heparin: Vaccine-induced immune thrombotic thrombocytopenia (VIIT), aggravation of VIIT and lack of efficacy: case report
Publicado: (2021)

Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol
por: Ghaziri, Dania, et al.
Publicado: (2023)

Use of fondaparinux in patients with heparin-induced thrombocytopenia on veno-venous extracorporeal membrane oxygenation: A three-patient case series report
por: Rychlíčková, Jitka, et al.
Publicado: (2023)

Impact of remote ischemic preconditioning preceding coronary artery bypass grafting on inducing neuroprotection (RIPCAGE): study protocol for a randomized controlled trial
por: Gasparovic, Hrvoje, et al.
Publicado: (2014)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
por: Spyropoulos, Alex C, et al.
Publicado: (2008)

AZD-1222/fondaparinux sodium: Thrombotic thrombocytopenia and lack of efficacy: case report
Publicado: (2021)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

The diagnosis of left ventricular assist device thrombosis
por: Gerds, H.Z.R., et al.
Publicado: (2015)

Perioperative management of left ventricular assist devices
por: Sanjay, O. P.
Publicado: (2016)

Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion
por: Zhao, Long, et al.
Publicado: (2021)

Propranolol efficiency in prevention of sustained ventricular tachycardia in patients with implanted cardioverter-defibrillator: a case series
por: Puljević, Mislav, et al.
Publicado: (2014)

Echocardiography in Left Ventricular Assist Device
por: Helmy, Sherif M., et al.
Publicado: (2010)

Left Ventricular Assist Device Management in the Emergency Department
por: Trinquero, Paul, et al.
Publicado: (2018)

Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
por: Williams, Jonathan S., et al.
Publicado: (2018)

Current Trends in Implantable Left Ventricular Assist Devices
por: Garbade, Jens, et al.
Publicado: (2011)

Choosing Between Left Ventricular Assist Devices and Biventricular Assist Devices
por: Shehab, Sajad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qo19ufaj2fbuken0t94o5f4kqj